NDAC Chair
This article was originally published in The Tan Sheet
Executive Summary
An "Appointed Chair" for the Nonprescription Drugs Advisory Committee will run meetings until a final selection is made for a permanent chair, according to FDA. Previous NDAC Chairman Alastair Wood, MD, concluded his term May 31. Wood will begin his role as a managing director at the New York-based private equity firm Symphony Capital in September (1"The Tan Sheet" May 8, 2006, p. 3) A permanent Chair normally is selected from the committee...